Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Lipsky

Showing results (21-30 of 271) with videos related to

Pageof 28
Sort By:
Arthritis Research|November 28, 2002
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndromeThomas Dörner, Peter E Lipsky
Frontiers in Medicine|June 14, 2021
Current Status of the Evaluation and Management of Lupus Patients and Future ProspectsSule Yavuz, Peter E Lipsky
Nature Clinical Practice. Rheumatology|October 31, 2007
CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseasesXavier Valencia, Peter E Lipsky
Nature Reviews. Rheumatology|October 14, 2016
Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLEThomas Dörner, Peter E Lipsky
Seminars in Arthritis and Rheumatism|July 5, 2020
Pegloticase treatment of chronic refractory gout: Update on efficacy and safetyNaomi Schlesinger, Peter E Lipsky
Arthritis and Rheumatism|July 13, 2002
CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosusAmrie C Grammer, Peter E Lipsky
Arthritis Research & Therapy|June 8, 2004
B cell abnormalities in systemic lupus erythematosusAmrie C Grammer, Peter E Lipsky
Trends in Immunology|July 1, 2006
Why do B cells mutate their immunoglobulin receptors?Nancy S Longo, Peter E Lipsky
Annual Review of Medicine|October 3, 2002
New concepts in the treatment of rheumatoid arthritisRaphaela Goldbach-Mansky, Peter E Lipsky
Rheumatic Diseases Clinics of North America|July 17, 2017
Drug Repositioning Strategies for the Identification of Novel Therapies for Rheumatic Autoimmune Inflammatory DiseasesAmrie C Grammer, Peter E Lipsky
Pageof 28

Showing results (21-30 of 271) with videos related to

Sort By:
Pageof 28
Arthritis Research|November 28, 2002
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndromeThomas Dörner, Peter E Lipsky
Frontiers in Medicine|June 14, 2021
Current Status of the Evaluation and Management of Lupus Patients and Future ProspectsSule Yavuz, Peter E Lipsky
Nature Clinical Practice. Rheumatology|October 31, 2007
CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseasesXavier Valencia, Peter E Lipsky
Nature Reviews. Rheumatology|October 14, 2016
Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLEThomas Dörner, Peter E Lipsky
Seminars in Arthritis and Rheumatism|July 5, 2020
Pegloticase treatment of chronic refractory gout: Update on efficacy and safetyNaomi Schlesinger, Peter E Lipsky
Arthritis and Rheumatism|July 13, 2002
CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosusAmrie C Grammer, Peter E Lipsky
Arthritis Research & Therapy|June 8, 2004
B cell abnormalities in systemic lupus erythematosusAmrie C Grammer, Peter E Lipsky
Trends in Immunology|July 1, 2006
Why do B cells mutate their immunoglobulin receptors?Nancy S Longo, Peter E Lipsky
Annual Review of Medicine|October 3, 2002
New concepts in the treatment of rheumatoid arthritisRaphaela Goldbach-Mansky, Peter E Lipsky
Rheumatic Diseases Clinics of North America|July 17, 2017
Drug Repositioning Strategies for the Identification of Novel Therapies for Rheumatic Autoimmune Inflammatory DiseasesAmrie C Grammer, Peter E Lipsky
Pageof 28